Healthcare analysts provide insight into Relypsa Inc (NASDAQ:RLYP) and Aduro BioTech Inc (NASDAQ:ADRO) as Relypsa begins commercialization of Veltassa, a drug to treat hyperkalemia, …
Aduro Bio Tech Inc (NASDAQ:ADRO) begins trading on Wednesday morning at 10:25 ET having completed a $119 million IPO that values the immunotherapy …